NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
14.38
+0.15 (1.05%)
Jul 15, 2026, 12:13 PM EDT - Market open
NeoGenomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 745.97 | 727.33 | 660.57 | 591.64 | 509.73 | 484.33 | |
Revenue Growth (YoY) | 10.95% | 10.11% | 11.65% | 16.07% | 5.24% | 8.97% |
Cost of Revenue | 424.06 | 413.04 | 370.47 | 347.04 | 321.83 | 297.27 |
Gross Profit | 238.57 | 314.29 | 290.1 | 244.6 | 187.9 | 187.06 |
Selling, General & Admin | 364.03 | 365.34 | 344.39 | 313.94 | 310.68 | 283.94 |
Research & Development | 36.43 | 37.08 | 31.16 | 27.31 | 30.33 | 21.87 |
Other Operating Expenses | 27.75 | 27.75 | 6.66 | 11.09 | 4.52 | - |
Total Operating Expenses | 428.21 | 430.17 | 382.21 | 352.34 | 345.52 | 305.81 |
Operating Income | -106.3 | -115.88 | -92.11 | -107.74 | -157.62 | -118.75 |
Interest Income | -6.62 | -9.07 | -18.43 | -16.9 | -6.08 | 8.22 |
Interest Expense | -2.73 | -3.75 | -6.62 | -6.91 | -7.58 | 3.14 |
Other Non-Operating Income (Expense) | -0.22 | -0.3 | 0.38 | -0.64 | 0.21 | -108.76 |
Total Non-Operating Income (Expense) | -9.57 | -13.12 | -24.67 | -24.45 | -13.44 | -97.4 |
Pretax Income | -102.19 | -110.27 | -80.68 | -97.1 | -159.34 | -15.08 |
Provision for Income Taxes | -2.98 | -2.24 | -1.95 | -9.13 | -15.09 | -6.73 |
Net Income | -99.21 | -108.03 | -78.73 | -87.97 | -144.25 | -8.35 |
Net Income to Common | -99.21 | -108.03 | -78.73 | -87.97 | -144.25 | -8.35 |
Shares Outstanding (Basic) | 129 | 128 | 127 | 126 | 124 | 120 |
Shares Outstanding (Diluted) | 129 | 128 | 127 | 126 | 124 | 120 |
Shares Change (YoY) | 1.24% | 1.14% | 0.92% | 1.03% | 3.55% | 7.31% |
EPS (Basic) | -0.77 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
EPS (Diluted) | -0.77 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
Free Cash Flow | -5.09 | -21.78 | -34.04 | -30.71 | -96.88 | -90.87 |
Free Cash Flow Per Share | -0.04 | -0.17 | -0.27 | -0.24 | -0.78 | -0.76 |
Gross Margin | 31.98% | 43.21% | 43.92% | 41.34% | 36.86% | 38.62% |
Operating Margin | -14.25% | -15.93% | -13.94% | -18.21% | -30.92% | -24.52% |
Profit Margin | -13.30% | -14.85% | -11.92% | -14.87% | -28.30% | -1.72% |
FCF Margin | -0.68% | -2.99% | -5.15% | -5.19% | -19.01% | -18.76% |
EBITDA | -39.79 | -48.06 | -19.56 | -35.15 | -88.19 | -65.4 |
EBITDA Margin | -5.33% | -6.61% | -2.96% | -5.94% | -17.30% | -13.50% |
EBIT | -106.3 | -115.88 | -92.11 | -107.74 | -157.62 | -118.75 |
EBIT Margin | -14.25% | -15.93% | -13.94% | -18.21% | -30.92% | -24.52% |
Effective Tax Rate | 2.92% | 2.03% | 2.42% | 9.40% | 9.47% | 44.63% |